Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Higher detection rate of JAK2 mutation using plasma

Wanlong Ma, Hagop Kantarjian, Xi Zhang, Weimin Sun, Arlene M. Buller, Iman Jilani, Joyce G. Schwartz, Francis Giles, Maher Albitar

Blood (2008) 111 (7): 3906–3907.

https://doi.org/10.1182/blood-2008-02-139188

Published: 2008

Journal Articles

Overexpression of JAK2 mRNA in Chronic Myeloproliferative Disease and Its Implication on Mutation Testing and Biology of Disease.

Wanlong Ma, Xi Zhang, Iman Jilani, Ph.D., Zhong Zhang, M.D., Hagop Kantarjian, M.D., Srdan Verstovsek, M.D., Francis Giles, M.D., Susan O’Brien, M.D., Maher Albitar, M.D.

Blood (2007) 110 (11): 2554.

https://doi.org/10.1182/blood.V110.11.2554.2554

Published: 2007

Journal Articles

Higher Sensitivity and Detection of Homozygous/Hemizygous State of JAK2 Mutation Using Plasma.

Wanlong Ma, Xi Zhang, Weimin Sun, Ph.D, Joyce Schwartz, M.D., Arlene Buller, Ph.D., Iman Jilani, Ph.D., Hagop Kantarjian, M.D., Francis Giles, M.D., Maher Albitar, M.D.

Blood (2007) 110 (11): 4663.

https://doi.org/10.1182/blood.V110.11.4663.4663

Published: 2007

Journal Articles

Activity of Circulating Proteasomes Correlates with Clinical Behavior in Patients with Chronic Myeloid Leukemia.

Wanlong Ma, Hagop Kantarjian, M.D., Amber Donahue, Ph.D., Xi Zhang, Susan O’Brien, M.D., Iman Jilani, Ph.D., Elihu Estey, M.D., Zeev Estrov, M.D., Jorge Cortes, M.D., Michael Keating, M.D., Francis Giles, M.D., Maher Albitar, M.D.

Blood (2007) 110 (11): 4546.

https://doi.org/10.1182/blood.V110.11.4546.4546

Published: 2007

Journal Articles

Proteasome Chymotrypsin-Like Activity in Plasma Is a Major Predictor of Outcome in Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Normal Karyotype.

Wanlong Ma, Iman Jilani, Ph.D., Benjamin Bekele, Hagop Kantarjian, M.D., Amber Donahue, Ph.D., Xi Zhang, Zhong Zhang, M.D., Susan O’Brien, M.D., Elihu Estey, M.D., Zeev Estrov, M.D., Jorge Cortes, M.D., Michael Keating, M.D., Francis Giles, M.D., Maher Albitar, M.D.

Blood (2007) 110 (11): 2837.

https://doi.org/10.1182/blood.V110.11.2837.2837

Published: 2007

Journal Articles

High Levels of Circulating HSP70 Levels in Patients with Chronic Myeloid Leukemia and Correlation with Resistance to Therapy with Imatinib.

Richard Tseng, PhD, Chen-Hsiung Yeh, Ph.D., Iman Jilani, Ph.D., Zhong Zhang, M.D., Hagop Kantarjian, M.D., Jorge Cortes, M.D., Susan O’Brien, M.D., Francis Giles, M.D., Alison Hannah, Ph.D., Zeev Estrov, M.D., Michael Keating, M.D., Maher Albitar, M.D.

Blood (2007) 110 (11): 2922.

https://doi.org/10.1182/blood.V110.11.2922.2922

Published: 2007

Journal Articles

Detection of Nucleophosmin Gene Mutations in Plasma from Patients with Acute Myeloid Leukemia: Clinical Significance and Implications.

Wanlong Ma, Xi Zhang, Iman Jilani, Ph.D., Farhad Ravandi, Elihu Estey, M.D., Hagop Kantarjian, M.D., Francis Giles, M.D., Mohammad Sheikholeslami, M.D., Michael Keating, M.D., Maher Albitar, M.D.

Blood (2007) 110 (11): 2855.

https://doi.org/10.1182/blood.V110.11.2855.2855

Published: 2007

Journal Articles

Correlation of New Method for Measuring Plasma Myeloperoxidase with Clinical Behavior in Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Adam Abdool, Xiugiang Wang, Iman Jilani, Ph.D., Weidong Zhou, M.D., Hagop Kantargian, M.D., Elihu Estey, M.D., Francis Giles, M.D., Maher Albitar, M.D.

Blood (2007) 110 (11): 4321.

https://doi.org/10.1182/blood.V110.11.4321.4321

Published: 2007

Journal Articles

Clinical Significance of Free Circulating CD4 and CD8 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Adam Abdool, Francis Giles, M.D., Menna Hodge, Susan O’Brien, M.D., Michael Keating, M.D., Iman Jilani, PhD, Hagop Kantarjian, M.D., Elihu Estey, M.D., Maher Albitar, M.D.

Blood (2006) 108 (11): 1889.

https://doi.org/10.1182/blood.V108.11.1889.1889

Published: 2006

Journal Articles

Clinical Significance of Free Circulating CD34 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Menna Hodge, Francis Giles, M.D., Adam Abdool, M.D., Susan O’Brien, M.D., Michael Keating, M.D., Iman Jilani, PhD, Zeev Estrov, M.D., Elihu Estey, M.D., Hagop Kantarjian, M.D., Maher Albitar, M.D.

Blood (2006) 108 (11): 4495.

https://doi.org/10.1182/blood.V108.11.4495.4495

Published: 2006

Journal Articles

Variations in Proteasome Enzymatic Activities in Plasma of Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome and Their Value in Predicting Clinical Behavior.

Wanlong Ma, Francis Giles, M.D., Susan O’Brien, M.D., Iman Jilani, PhD, Xi Zhang, Zeev Estrov, M.D., Elihu Estey, M.D., Alessandra Ferrajoli, M.D., Michael Keating, M.D., Maher Albitar, M.D.

Blood (2006) 108 (11): 4497.

https://doi.org/10.1182/blood.V108.11.4497.4497

Published: 2006

Journal Articles

Clinical Significance of Free Circulating CD33 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Menna Hodge, Francis Giles, M.D., Adam Abdool, Susan O’Brien, M.D., Michael Keating, M.D., Iman Jilani, PhD, Zeev Estrov, M.D., Elihu Estey, M.D., Hagop Kantarjian, M.D., Maher Albitar, M.D.

Blood (2006) 108 (11): 4502.

https://doi.org/10.1182/blood.V108.11.4502.4502

Published: 2006

Journal Articles

Measurement and Clinical Relevance of Proteasome Enzymatic Activity in Plasma of Patients with Acute Lymphoblastic Leukemia.

Wanlong Ma, Hagop Kantarjian, M.D., Susan O’Brien, M.D., Iman Jilani, PhD, Xi Zhang, M.D., Zeev Zestrov, M.D., Elihu Estey, M.D, Alessandra Ferrajoli, M.D., Michael Keating, M.D., Francis Giles, M.D., Maher Albitar, M.D.

Blood (2006) 108 (11): 4475.

https://doi.org/10.1182/blood.V108.11.4475.4475

Published: 2006

Journal Articles

Epidermal Growth Factor Is an Independent Prognostic Factor in Patients with Chronic Lymphocytic Leukemia.

Zhong Zhang, MD, Susan O’Brien, M.D., Michael Keating, M.D., Iman Jilani, PhD, Hagop Kantarjian, M.D., Zeev Estrov, M.D., Alessandra Ferrajoli, M.D., Francis Giles, M.D., Maher Albitar, M.D.

Blood (2006) 108 (11): 4952.

https://doi.org/10.1182/blood.V108.11.4952.4952

Published: 2006

Journal Articles

Variations in Proteasome Enzymatic Activities in Plasma of Patients with Chronic Lymphocytic Leukemia and Their Value in Predicting Clinical Behavior.

Wanlong Ma, Susan O’Brien, M.D., Iman Jilani, PhD, Xi Zhang, Hagop Kantarjian, M.D., Zeev Estov, M.D., Alessandra Ferrajoli, M.D., Michael Keating, M.D., Francis Giles, M.D., Maher Albitar, M.D.

Blood (2006) 108 (11): 4946.

https://doi.org/10.1182/blood.V108.11.4946.4946

Published: 2006

Journal Articles

Clinical Significance of Free Circulating CD3 and CD5 in Patients with Chronic Lymphocytic Leukemia.

Menna Hodge, Susan O’Brien, M.D., Adam Abdool, Michael Keating, M.D., Iman Jilani, PhD, Hagop Kantarjian, M.D., Alessandra Ferrajoli, M.D., Zeev Estrov, M.D., Francis Giles, M.D., Maher Albitar, M.D.

Blood (2006) 108 (11): 4947.

https://doi.org/10.1182/blood.V108.11.4947.4947

Published: 2006

Journal Articles

Interleukin-1 Receptor Antagonist and Interleukin-1 beta: Different Roles in Patients with Chronic Lymphocytic Leukemia.

Zhong Zhang, MD, Susan O’Brien, M.D., Michael Keating, M.D., Iman Jilani, PhD, Hagop Kantarjian, M.D., Zeev Estrov, M.D., Alessandra Ferrajoli, M.D., Francis Giles, M.D., Maher Albitar, M.D.

Blood (2006) 108 (11): 4948.

https://doi.org/10.1182/blood.V108.11.4948.4948

Published: 2006

Journal Articles

Plasma thrombopoietin compared with immunoglobulin heavy-chain mutation status as a predictor of survival in chronic lymphocytic leukemia

Charles Koller, B. Nebiyou Bekele, Xian Zhou, Charles Park, Zeev Estrov, Susan O'Brien, Michael Keating, Iman Jilani, Francis J. Giles, Hagop M. Kantarjian, Maher Albitar

Blood (2006) 108 (3): 1001–1006.

https://doi.org/10.1182/blood-2005-05-2110

Published: 2006

Journal Articles

Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia

Stefan Faderl, Kim-Anh Do, Marcella M. Johnson, Michael Keating, Susan O'Brien, Iman Jilani, Alessandra Ferrajoli, Farhad Ravandi-Kashani, Christine Aguilar, Amanda Dey, Deborah A. Thomas, Francis J. Giles, Hagop M. Kantarjian, Maher Albitar

Blood (2005) 106 (13): 4303–4307.

https://doi.org/10.1182/blood-2005-03-1010

Published: 2005

Journal Articles

Circulating Myeloperoxidase (MPO) as a Tumor Marker in Patients with Chronic Myeloid Leukemia (CML).

Iman Jilani, MS, Ted Vincente, BS, Homan Faraji, BS, Francis J. Giles, MD, Jorge Cortes, MD, Hagop M. Kantarjian, MD, Maher Albitar, MD

Blood (2004) 104 (11): 4679.

https://doi.org/10.1182/blood.V104.11.4679.4679

Published: 2004

NARROW

Higher detection rate of JAK2 mutation using plasma

Overexpression of JAK2 mRNA in Chronic Myeloproliferative Disease and Its Implication on Mutation Testing and Biology of Disease.

Higher Sensitivity and Detection of Homozygous/Hemizygous State of JAK2 Mutation Using Plasma.

Activity of Circulating Proteasomes Correlates with Clinical Behavior in Patients with Chronic Myeloid Leukemia.

Proteasome Chymotrypsin-Like Activity in Plasma Is a Major Predictor of Outcome in Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Normal Karyotype.

High Levels of Circulating HSP70 Levels in Patients with Chronic Myeloid Leukemia and Correlation with Resistance to Therapy with Imatinib.

Detection of Nucleophosmin Gene Mutations in Plasma from Patients with Acute Myeloid Leukemia: Clinical Significance and Implications.

Correlation of New Method for Measuring Plasma Myeloperoxidase with Clinical Behavior in Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Clinical Significance of Free Circulating CD4 and CD8 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Clinical Significance of Free Circulating CD34 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Variations in Proteasome Enzymatic Activities in Plasma of Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome and Their Value in Predicting Clinical Behavior.

Clinical Significance of Free Circulating CD33 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Measurement and Clinical Relevance of Proteasome Enzymatic Activity in Plasma of Patients with Acute Lymphoblastic Leukemia.

Epidermal Growth Factor Is an Independent Prognostic Factor in Patients with Chronic Lymphocytic Leukemia.

Variations in Proteasome Enzymatic Activities in Plasma of Patients with Chronic Lymphocytic Leukemia and Their Value in Predicting Clinical Behavior.

Clinical Significance of Free Circulating CD3 and CD5 in Patients with Chronic Lymphocytic Leukemia.

Interleukin-1 Receptor Antagonist and Interleukin-1 beta: Different Roles in Patients with Chronic Lymphocytic Leukemia.

Plasma thrombopoietin compared with immunoglobulin heavy-chain mutation status as a predictor of survival in chronic lymphocytic leukemia

Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia

Circulating Myeloperoxidase (MPO) as a Tumor Marker in Patients with Chronic Myeloid Leukemia (CML).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only